The Stofwisselkracht Foundation raises funds for research into metabolic diseases in a sporting and original way.
Walinka van Tol, Federica Conte and Mohammad Alsady, theme Disorders of movement, received two Stofwisselkracht Foundation grants of 46.000 euro for research into glycosylation related neuromuscular diseases.
More information about the Stofwisselkracht Foundation (only in Dutch): link.
Mohammad Alsady (l) Walinka van Tol (m) Federica Conte (r)
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Radboud Young Academy safeguards the future of science
21 January 2021New platform to provide advice on policy, create an interdisciplinary network of early career scientists, and promote career development.
read more
New research through grants for Radboudumc researchers
14 January 2021Several researchers at the Radboudumc have received grants to start new studies, including on rare diseases, liver disease and cancer metastases. These are grants from the Dutch Research Council, European Joint Programme on Rare Diseases and the Gastric Liver Disease Foundation.
read more
Should we prepare for a corona-related depression wave? Indira Tendolkar and Eric Ruhé talk about their research projects
13 January 2021Since the outbreak of the SARS-CoV-2, many of us have been staying at home in order to limit our social interactions, to keep ourselves and others safe from the virus. Yet, there’s also concern about what social distancing and anxiety generated by media reports are doing to people's mental health.
read more
Nael Nadif Kasri receives 250k Euro from European Joint Programme on Rare Diseases (EJP-RD)
7 January 2021Nael Nadif Kasri, Department of Cognitive Neurosciences, Human Genetics theme Neurodevelopmental disorders, received 250,000 Euro as a member of the SCN1A-UP! consortium.
read more
Werner Koopman received funding from the European Joint Programme on Rare Diseases
22 December 2020In a large consortium, Werner Koopman will apply a cell-based reprogramming strategy for drug repositioning in patients with mitochondrial DNA-associated Leigh Syndrome.
read more
Apathy is an early predictor of dementia
16 December 2020Apathy predicts some forms of dementia years before the first symptoms appear. This is the main finding of Rogier Kievit of the Radboudumc and colleagues from the University of Cambridge in their publication today in Alzheimer's & Dementia.
read more